UNISENSE
DEAD

Serial Number

79301651

Owner

SB Solutions Inc.

Filing Date

Nov 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

UNISENSE Trademark

Serial Number: 79301651

UNISENSE is a trademark filed by SB Solutions Inc. on November 20, 2020. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

SB Solutions Inc. (4 trademarks)

No. 401 3, 50, UNIST gil, Eonyang eup, U
Ulsan 44919 , KR

Entity Type: 03

Trademark Details

Filing Date

November 20, 2020

Registration Date

Not Registered

Goods & Services

Blood glucose meters; continuous blood glucose monitor; blood glucose monitors; blood glucose testing apparatus; apparatus for measuring blood glucose; devices for measuring blood sugar; medical instruments; buccal tubes; contraceptive apparatus; triangular bandages [supportive]; electric massage apparatus for household use; gloves for medical purposes; masks for medical purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 29, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 29, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 27, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 8, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 8, 2022 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 30, 2021 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 29, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 29, 2021 ABN2
REFUSAL PROCESSED BY IB
May 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 11, 2021 RFCS
REFUSAL PROCESSED BY MPU
May 11, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 8, 2021 RFCR
NON-FINAL ACTION WRITTEN
May 7, 2021 CNRT
ASSIGNED TO EXAMINER
May 5, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 12, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 7, 2021 REPR